@dansfera: The moment a company shifts focus from innovation to pure profitability, something crucial gets lost. It’s a common corporate cycle: once expansion slows down, the aggressive push into new therapeutic areas takes a backseat to operational efficiency. Does this pivot eventually stifle their ability to lead in the long run? It’s a classic case of growth versus the bottom line. #businessstrategy #corporateculture #biotech #industryinsights #growthmindset